Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study

BACKGROUND: After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients with squamous cell carcinoma (SCC). An active surveillance strategy has been proposed for SCC patients with clinically complete re...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Zhang, Xiaobin, Eyck, Ben M., Yang, Yang, Liu, Jun, Chao, Yin-Kai, Hou, Ming-Mo, Hung, Tsung-Min, Pang, Qingsong, Yu, Zhen-Tao, Jiang, Hongjing, Law, Simon, Wong, Ian, Lam, Ka-On, van der Wilk, Berend J., van der Gaast, Ate, Spaander, Manon C. W., Valkema, Roelf, Lagarde, Sjoerd M., Wijnhoven, Bas P. L., van Lanschot, J. Jan B., Li, Zhigang
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060643/
https://ncbi.nlm.nih.gov/pubmed/32143580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6669-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items